LGALS3 and congestive heart failure: YQYYHXBXD combined with biomedicine medicine can reduce the levels of serum sST2, galectin-3, LN, PIIIP, and serum IL-1β, TNF-α, hs-CRP, MMP-9, and other inflammatory factors in patients with CHF, and the degree of adverse reactions in the two groups was mild, which did not affect the clinical observations.